The result photos and meibography images for this study look very promising!
"7 June 2017 - Clinical safety and efficacy of vitamin D3 analog ointment for treatment of obstructive meibomian gland dysfunction
The clinical scores for plugging of meibomian gland orifices and lid margin vascularity as well as BUT, meibum grade, and meibomian gland area were significantly improved after the 8-week treatment period compared with pretreatment values. Topical eyelid application of an analog of the active form of vitamin D3 was found to be safe as well as to improve the condition of patients.
Our results thus suggest that analogs of the active form of vitamin D3 may be effective for the treatment of obstructive meibomian gland dysfunction and that they warrant further investigation in clinical trials with larger numbers of patients."
https://bmcophthalmol.biomedcentral....886-017-0482-7
Patent for the vitamin D3 ointment:
https://www.google.com/patents/EP3015107A1?cl=en
"7 June 2017 - Clinical safety and efficacy of vitamin D3 analog ointment for treatment of obstructive meibomian gland dysfunction
The clinical scores for plugging of meibomian gland orifices and lid margin vascularity as well as BUT, meibum grade, and meibomian gland area were significantly improved after the 8-week treatment period compared with pretreatment values. Topical eyelid application of an analog of the active form of vitamin D3 was found to be safe as well as to improve the condition of patients.
Our results thus suggest that analogs of the active form of vitamin D3 may be effective for the treatment of obstructive meibomian gland dysfunction and that they warrant further investigation in clinical trials with larger numbers of patients."
https://bmcophthalmol.biomedcentral....886-017-0482-7
Patent for the vitamin D3 ointment:
https://www.google.com/patents/EP3015107A1?cl=en
Comment